BioCryst gets a big boost from its latest HAE data, but it still faces a dangerous high wire act and giant rivals
A little more than a year ago, shares of Research Triangle Park, NC-based BioCryst $BCRX were crushed by a failed Phase II trial for their …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
